5,7-Dibromo-2,3-dihydrothieno[3,4-b][1,4]dioxine, 95.0%, 10g

N,N-Dimethylacetamide, anhydrous, 99.0%, 25ml

(4-(OXETAN-3-YL)PHENYL)BORONIC ACID, 95.0%, 250mg

3-Bromo-6,7-dihydro-5H-pyrrolo[1,2-a]imidazole, 25g

(S)-4-Benzyl-3-(5-bromopentanoyl)oxazolidin-2-one, 98%, 1g

[6-[[(3S)-Tetrahydrofuran-3-yl]oxymethyl]-2-pyridyl]methanamine dihydrochloride, 98%, 250mg

N6-Butyryl-L-lysine, 97%, 10g

4-(3-Chloro-5-(trifluoromethyl)2-pyridyloxy)phenylthiourea, 95%, 2g

Methyl Laurate [Standard Material for GC]>99.5%(GC)5mL

Objectif IOS corrigé à l'infini EPLPHi 20x/0,40 phase E-Plan. Distance de travail 2,61 mm

3,3-dimethyl-2-pyrrolidinone, 95.0%, 100mg

tert-Butyl 4-(ethylamino)piperidine-1-carboxylate, 95.0%, 5g

3-(DIFLUOROMETHYL)CYCLOBUTANONE, 95.0%, 500mg